BioMarin Pharmaceuticals BMRN Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's total current assets?
- BioMarin Pharmaceuticals (BMRN) reported total current assets of $4.61B in Q1 2026.
- How has BioMarin Pharmaceuticals's total current assets changed year-over-year?
- BioMarin Pharmaceuticals's total current assets increased by 32.8% year-over-year, from $3.47B to $4.61B.
- What is the long-term trend for BioMarin Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's total current assets has grown at a 11.0% compound annual growth rate (CAGR), from $2.34B to $3.95B.
- What does total current assets mean?
- The total value of all assets the company expects to turn into cash within one year.
- How do you interpret total current assets?
- A higher total indicates strong short-term liquidity, while a declining trend may signal potential cash flow constraints.
- How does total current assets compare across companies?
- Used by investors to compare the short-term financial strength of companies within the same industry sector.